Literature DB >> 29289265

Utility of Serum IgG4 Levels in a Multiethnic Population.

Ruyu Qi1, Luke Y C Chen2, Sujin Park2, Robert Irvine3, Michael A Seidman4, John T Kelsall5, David Collins5, Vivian Yin6, Graham W Slack4, Andre Mattman7, Eric Lam8, Mollie N Carruthers9.   

Abstract

BACKGROUND: IgG4-related disease (IgG4-RD) is a recently recognized condition defined by characteristic histopathologic findings in affected organs. Serum IgG4 concentration is often but not always elevated. The sensitivity and specificity of serum IgG4 vary greatly across studies and has been anecdotally associated to ethnicity. Our study was conducted to investigate the difference in serum IgG4 levels between Asian and non-Asian patients with IgG4-RD.
METHODS: This is a single-center retrospective study of 26 Asian and 10 non-Asian patients with histologically confirmed IgG4-RD. Serum IgG4 levels, clinical features and other laboratory findings were compared between the 2 groups, 31 Asian and 11 non-Asian patients with non-IgG4-RD rheumatic diseases were randomly identified to evaluate test characteristics of serum IgG4 measurement.
RESULTS: Median serum IgG4 at time of diagnosis was significantly higher in Asian (median = 11.2g/L, interquartile range: 4.6-19.7) than non-Asian patients (median = 2.9g/L, interquartile range: 0.7-5.4, P = 0.0094), as well as the median serum IgG and total protein. Asian patients had more eosinophilia and polyclonal hypergammaglobulinemia than non-Asian patients (P = 0.016 and 0.001, respectively). Test sensitivity was higher in Asian (96%) than non-Asian patients (67%), whereas test specificity was higher in non-Asian patients (91% versus 71%).
CONCLUSION: Asian patients with IgG4-RD have more exuberant serum IgG4, IgG and polyclonal hypergammaglobulinemia than non-Asian patients; the mechanism of this difference requires further study. These findings have significant clinical importance and must be accounted for in the diagnostic workup of patients in multiethnic settings.
Copyright © 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asian; Ethnicity; IgG4-RD; Serum IgG4

Mesh:

Substances:

Year:  2017        PMID: 29289265     DOI: 10.1016/j.amjms.2017.08.014

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease.

Authors:  Hang Liu; Cory A Perugino; Musie Ghebremichael; Zachary S Wallace; Sydney B Montesi; John H Stone; Shiv Pillai
Journal:  Arthritis Rheumatol       Date:  2020-02-10       Impact factor: 10.995

2.  Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center.

Authors:  Eric J Zhao; Mollie N Carruthers; Charles H Li; Andre Mattman; Luke Y C Chen
Journal:  Haematologica       Date:  2019-06-27       Impact factor: 9.941

3.  Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.

Authors:  Hyon K Choi; John H Stone; Zachary S Wallace; Yuqing Zhang; Cory A Perugino; Ray Naden
Journal:  Ann Rheum Dis       Date:  2019-01-05       Impact factor: 19.103

4.  Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race.

Authors:  Tyler Harkness; Xiaoqing Fu; Yuqing Zhang; Hyon K Choi; John H Stone; Kimberly G Blumenthal; Zachary S Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-27       Impact factor: 6.347

5.  The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases.

Authors:  Kai-Ming Li; Man-Hua Xu; Xia Wu; Wei-Min He
Journal:  Onco Targets Ther       Date:  2020-06-17       Impact factor: 4.147

Review 6.  IgG4-related disease: what a hematologist needs to know.

Authors:  Luke Y C Chen; Andre Mattman; Michael A Seidman; Mollie N Carruthers
Journal:  Haematologica       Date:  2019-01-31       Impact factor: 9.941

7.  Malignancy Risk of Immunoglobin G4-Related Disease: Evidence from a Large Cohort Multicenter Retrospective Study.

Authors:  Yanying Liu; Jiangnan Fu; Xiaoran Ning; Huijuan Li; Xiangbo Ma; Kunkun Wang; Wenjie Bian; Yuxin Zhang; Guangyan Yu; Zhanguo Li
Journal:  Rheumatol Ther       Date:  2021-06-28

Review 8.  Active IgG4-related disease with bone marrow involvement: a report of 2 cases and case-based review.

Authors:  Shiyi Liu; Hui Wang; Tao Su
Journal:  Eur J Med Res       Date:  2022-02-02       Impact factor: 2.175

9.  IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male.

Authors:  Aria Jazdarehee; Azin Ahrari; Drew Bowie; Silvia D Chang; Henry Tran; Shahin Jamal; Luke Y C Chen; Karen C Tran
Journal:  BMC Urol       Date:  2022-03-11       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.